[1] [2] It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists , which work by mimicking the action of the naturally occurring hormone GLP-1
S., Claux, O., Abert-Vian, M., Tabasso, S., Cravotto, G., & Chemat, F
Contact Us Today
GLP1 MODULATION OF THE HYPOTHALAMICPITUITARYOVARIAN AXIS ENHANCES FEMALE FERTILITY As described above, obesity is associated with diabetes and insulin resistance, sharing a common link with metabolic disorders like PCOS
As a class of drugs, GLP-1s have been shown to result in weight loss.[2] Common side effects of GLP-1s include nausea, vomiting, diarrhea, constipation, injection site reactions, headache, hypoglycemia, dyspepsia, fatigue, dizziness, abdominal pain, and gastroenteritis.[1-4] All GLP-1s carry a boxed warning for the risk of thyroid c-cell tumors and a contraindication for a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Advani SM, Swartz MD, Loree J, Davis JS, Sarsashek AM, Lam M, Lee MS, Bressler J, Lopez DS, Daniel CR, Morris V, Shureqi I, Kee B, Dasari A, Vilar E, Overman M, Hamilton S, Maru D, Braithwaite D, Kopetz S
.png)
